John G YoungerCareer Moves for Life Scientists: Where is the Science Actually Leading You?Part of the Shock Society 2022 Annual ConferenceAug 24, 2022Aug 24, 2022
John G YoungerEarly Commercialization and Financing Challenges with New Materials2nd Annual MXene Global ConferenceAug 24, 2022Aug 24, 2022
John G YoungerinBioeconomy.XYZA Hot Summer in the Valley of DeathWhat post-pandemic economic conditions mean for seed-stage life science venturesAug 8, 2022Aug 8, 2022
John G YoungerinBioeconomy.XYZAn Angel Investor’s Primer to SBIR GrantsChampioned mostly as an excellent source of nondiluting capital, several aspects of the program may take companies’ eyes of the ballMar 9, 2022Mar 9, 2022
John G YoungerinBioeconomy.XYZWhere New Medical Devices Come FromMapping the US FDA 510(k) and Pre-Market Approval LandscapeNov 29, 2021Nov 29, 2021
John G YoungerinBioeconomy.XYZMapping the Medical Device Start-Up EcosystemAnd identifying the niches where these companies most often thriveOct 11, 2021Oct 11, 2021
John G YoungerCOVID-19 Partnerships: ArgoPond Teams with Doctors Emma Meagher and Ian Frank, University of…During the COVID-19 pandemic, Argo Pond provided research strategic advising and clinical trial oversight to research teams across the US…Oct 3, 2021Oct 3, 2021
John G YoungerCOVID-19 Partnerships: ArgoPond Teams with Katharine Bar, University of PennsylvaniaDuring the COVID-19 pandemic, ArgoPond provided services to several research teams by leading clinical trial Data and Safety Monitoring…Oct 3, 2021Oct 3, 2021
John G YoungerCOVID-19 Research Notes: ArgoPond Teams with Julio Chirinos and Jordana Cohen, University of…During the COVID-19 pandemic, ArgoPond provided services to several research teams by leading clinical trial Data and Safety Monitoring…Oct 3, 2021Oct 3, 2021
John G YoungerinBioeconomy.XYZAmerica’s Biggest Biotech AngelThe NIH’s Billion Dollar Annual Boost to US Biotech EcosystemsJul 23, 2021Jul 23, 2021
